查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1375859

心臟生物标记市场规模、份额、趋势分析报告：按类型、应用、最终用途、地区和细分市场预测，2023-2030 年

Cardiac Biomarkers Market Size, Share & Trends Analysis Report By Type (Troponin, CK-MB, Myoglobin, BNP And NT-proBNP), By Application (Acute Coronary Syndrome, Myocardial Infarction), By End-use, By Region, And Segment Forecasts, 2023 - 2030
出版日期: | 出版商: Grand View Research | 英文 120 Pages | 商品交期: 2-10个工作天内

价格

心臟生物标记市场成长与趋势：

Grand View Research, Inc.最新报告显示，预计2023年至2030年全球心臟生物标记市场规模将以14.6%的年复合成长率增长，2030年达到478.8亿美元。

急性冠状动脉症候群综合症（ACS）盛行率的增加以及生物标记技术的进步预计将推动市场成长。对心臟疾病早期诊断和预后的认识不断提高预计将进一步推动市场。

根据NCBI预测，2021年美国将有超过1,550万人罹患心臟疾病。胸痛是急诊就诊最常见的原因之一。心臟病是美国的主要原因之一，估计每 41 秒就有 1 人心臟病发作。心臟生物标记在 ACS 诊断中发挥重要作用，有助于更快地做出治疗决策。

在急性冠状动脉症候群的风险分层和诊断中越来越多地采用生物标记正在推动需求。不健康的生活方式会增加急性冠状动脉症候群和心肌梗塞的盛行率。 PoC 诊断的日益普及正在促进心臟标记的使用并推动细分市场的创新。医院和 PoC 环境中采用心臟生物标记的范式转变归因于与心肌肌钙蛋白 I 和心肌肌钙蛋白 T 敏感性相关的检测的最新进展。

此外，新型检测方法的不断增加是预计未来年度推动市场成长的关键因素之一。这正在推动新参与企业进入这一领域。例如，2021年5月，深圳迈瑞生物医疗电子宣布计画以6.61亿美元收购销售心臟生物标记的公司HyTest。原料自家公司正成为企业确保原料稳定供应的首要领域。

心臟生物标记市场报告亮点

  • 按类型划分，肌钙蛋白在 2022 年的销售额中所占份额最大，因为它经常用于心血管疾病的诊断。
  • 从应用来看，由于急性冠状动脉症候群盛行率的增加以及生物标记在疾病诊断和治疗中的应用不断扩大，预计急性冠状动脉领域将在预测期内以有利的速度增长。
  • 由于拥有发达的医疗保健系统，可以轻鬆采用心臟生物标记作为诊断和预后工具，北美将在 2022 年主导全球市场。
  • 预计亚太地区在预测期内将显着成长。这是由于中国和日本等国家的目标人口广泛，并且有大公司投资研发。

目录

第1章调查方法与范围

第2章执行摘要

第3章心臟生物标记市场变数、趋势和范围

  • 市场体系展望
    • 母市场展望
    • 相关/附随市场展望
  • 普及和成长前景图
  • 市场动态
    • 市场驱动因素分析
    • 市场抑制因素分析
  • 心臟生物标记市场分析工具
    • 产业分析-波特五力分析
    • PESTEL分析

第4章心臟生物标记：类型估计/趋势分析

  • 心臟生物标记市场：重点
  • 心臟生物标记市场：2022 年和 2030 年趋势和市场占有率分析
  • 肌钙蛋白
    • 2018年至2030年肌钙蛋白市场估计与预测
  • CK-MB
    • 2018年至2030年CK-MB市场估计与预测
  • 肌红蛋白
    • 2018年至2030年肌红蛋白市场估计与预测
  • BNP 和 NT-proBNP
    • 2018年至2030年BNP和NT-proBNP市场估计和预测
  • 其他的
    • 2018 年至 2030 年其他市场估计与预测

第5章心臟生物标记：应用估计和趋势分析

  • 心臟生物标记市场：重点
  • 心臟生物标记市场：2022 年和 2030 年趋势和市场占有率分析
  • 急性冠状动脉症候群
  • 心肌梗塞
  • 充血性心臟衰竭
  • 其他的

第6章心臟生物标记：最终用途估计和趋势分析

  • 心臟生物标记市场：重点
  • 心臟生物标记市场：2022 年和 2030 年趋势和市场占有率分析
  • 临床检查
    • 2018年至2030年临床检测市场估计与预测
  • 即时检测
    • 2018 年至 2030 年即时检测市场估计与预测

第7章心臟生物标记市场：区域估计和趋势分析

  • 区域展望
  • 按地区分類的心臟生物标记市场：要点
  • 北美洲
  • 欧洲
  • 亚太地区
  • 拉丁美洲
  • 中东/非洲

第8章竞争形势

  • 主要市场参与企业的最新趋势和影响分析
  • 公司/竞争分类
    • Abbott
    • Quidel Corporation
    • Siemens Healthineers GmbH
    • F. Hoffmann-La Roche Ltd.
    • Danaher
    • BIOMERIEUX
    • Bio-Rad Laboratories, Inc.
    • Randox Laboratories Ltd.
    • Creative Diagnostics
    • Life Diagnostics
Product Code: GVR-1-68038-083-5

Cardiac Biomarkers Market Growth & Trends:

The global cardiac biomarkers market size is expected to reach USD 47.88 billion by 2030, expanding at a CAGR of 14.6% from 2023 to 2030, according to a new report by Grand View Research, Inc.. The increasing prevalence of acute coronary syndrome (ACS), along with advancements in biomarker technologies, is expected to propel market growth. The rising awareness regarding early diagnosis and prognosis of cardiac diseases is expected to further drive the market.

According to the NCBI, in 2021, in the U.S., over 15.5 million people were affected by coronary heart disease. Chest pain is one of the most common reasons for emergency department visits. Heart disease is one of the major causes of death in the U.S. and it is estimated that a person has a heart attack every 41 seconds. Cardiac biomarkers play a significant role in ACS diagnosis and facilitate faster treatment decision-making, thereby making them crucial.

The improving adoption of biomarkers in risk stratification and diagnosis of the acute coronary syndrome is impelling the demand. An unhealthy lifestyle is driving the prevalence of acute coronary syndrome and myocardial infarction. The increasing adoption of PoC diagnostics is driving segment innovation, making use of cardiac markers easier. The paradigm shift in the adoption of cardiac biomarkers in hospitals and PoC settings can be attributed to the recent developments in assays pertaining to the sensitivity of cardiac troponin I and cardiac troponin T.

Moreover, the rise in the availability of novel assays is one of the major drivers anticipated to boost market growth in the upcoming years. This is driving the movement of new players in the segment. For instance, in May 2021, Shenzhen Mindray Bio-Medical Electronics announced its plan to acquire HyTest, which is involved in cardiac biomarkers sales, for USD 661 million. In-house production of raw materials is becoming an area of prime focus for companies to ensure a steady flow of raw materials.

Cardiac Biomarkers Market Report Highlights:

  • By type, the troponin segment held the largest revenue share in 2022 owing to its high usage in cardiovascular diseases diagnosis
  • Based on application, the acute coronary syndrome segment is expected to grow at a lucrative rate during the forecast period due to the increasing prevalence of coronary diseases and expanding applications of these biomarkers in the diagnosis and treatment of diseases
  • North America dominated the global market in 2022 owing to the presence of a developed healthcare system that facilitates easier adoption of cardiac biomarkers as a tool for diagnosis and prognosis
  • Asia Pacific is expected to grow at a significant rate during the forecast period. This can be attributed to the presence of a wide target population and leading companies that are making R&D investments in countries such as China and Japan

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
    • 1.1.1. Type
    • 1.1.2. Application
    • 1.1.3. End use
    • 1.1.4. Regional scope
    • 1.1.5. Estimates and forecast timeline
  • 1.2. Research Methodology
  • 1.3. Information Procurement
    • 1.3.1. Purchased database
    • 1.3.2. GVR's internal database
    • 1.3.3. Secondary sources
    • 1.3.4. Primary research
    • 1.3.5. Details of primary research
  • 1.4. Information or Data Analysis
  • 1.5. Market Formulation & Validation
  • 1.6. Model Details
  • 1.7. List of Secondary Sources
  • 1.8. List of Primary Sources
  • 1.9. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type outlook
    • 2.2.2. Application outlook
    • 2.2.3. End use outlook
    • 2.2.4. Regional outlook
  • 2.3. Competitive Insights

Chapter 3. Cardiac Biomarkers Market Variables, Trends & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent market outlook
    • 3.1.2. Related/ancillary market outlook
  • 3.2. Penetration & Growth Prospect Mapping
  • 3.3. Market Dynamics
    • 3.3.1. Market driver analysis
    • 3.3.2. Market restraint analysis
  • 3.4. Cardiac Biomarkers Market Analysis Tools
    • 3.4.1. Industry Analysis - Porter's
      • 3.4.1.1. Supplier power
      • 3.4.1.2. Buyer power
      • 3.4.1.3. Substitution threat
      • 3.4.1.4. Threat of new entrant
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Technological landscape
      • 3.4.2.3. Economic landscape

Chapter 4. Cardiac Biomarkers: Type Estimates & Trend Analysis

  • 4.1. Cardiac Biomarkers Market: Key Takeaways
  • 4.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
  • 4.3. Troponin
    • 4.3.1. Troponin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.4. CK-MB
    • 4.4.1. CK-MB market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.5. Myoglobin
    • 4.5.1. Myoglobin market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.6. BNP and NT-proBNP
    • 4.6.1. BNP and NT-proBNP market estimates and forecasts, 2018 to 2030 (USD Million)
  • 4.7. Others
    • 4.7.1. Others market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 5. Cardiac Biomarkers: Application Estimates & Trend Analysis

  • 5.1. Cardiac Biomarkers Market: Key Takeaways
  • 5.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
  • 5.3. Acute Coronary Syndrome
    • 5.3.1. Acute coronary syndrome market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.4. Myocardial Infarction
    • 5.4.1. Myocardial infarction market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.5. Congestive Heart Failure
    • 5.5.1. Congestive heart failure market estimates and forecasts, 2018 to 2030 (USD Million)
  • 5.6. Others
    • 5.6.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 6. Cardiac Biomarkers: End Use Estimates & Trend Analysis

  • 6.1. Cardiac Biomarkers Market: Key Takeaways
  • 6.2. Cardiac Biomarkers Market: Movement & Market Share Analysis, 2022 & 2030
  • 6.3. Laboratory Testing
    • 6.3.1. Laboratory testing market estimates and forecasts, 2018 to 2030 (USD Million)
  • 6.4. Point of Care Testing
    • 6.4.1. Point of care testing market estimates and forecasts, 2018 to 2030 (USD Million)

Chapter 7. Cardiac Biomarkers Market: Regional Estimates & Trend Analysis

  • 7.1. Regional Outlook
  • 7.2. Cardiac Biomarkers Market by Region: Key Takeaways
  • 7.3. North America
    • 7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.2. U.S.
      • 7.3.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.3.3. Canada
      • 7.3.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.4. Europe
    • 7.4.1. UK
      • 7.4.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.2. Germany
      • 7.4.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.3. France
      • 7.4.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.4. Italy
      • 7.4.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.5. Spain
      • 7.4.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.6. Denmark
      • 7.4.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.7. Sweden
      • 7.4.7.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.4.8. Norway
      • 7.4.8.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.5. Asia Pacific
    • 7.5.1. Japan
      • 7.5.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.2. China
      • 7.5.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.3. India
      • 7.5.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.4. Australia
      • 7.5.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.5. Thailand
      • 7.5.5.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.5.6. South Korea
      • 7.5.6.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.6. Latin America
    • 7.6.1. Brazil
      • 7.6.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.2. Mexico
      • 7.6.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.6.3. Argentina
      • 7.6.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
  • 7.7. MEA
    • 7.7.1. South Africa
      • 7.7.1.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.2. Saudi Arabia
      • 7.7.2.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.3. UAE
      • 7.7.3.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)
    • 7.7.4. Kuwait
      • 7.7.4.1. Market estimates and forecasts, 2018 - 2030 (Revenue, USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Recent Developments & Impact Analysis, By Key Market Participants
  • 8.2. Company/Competition Categorization
    • 8.2.1. Abbott
      • 8.2.1.1. Company overview
      • 8.2.1.2. Financial performance
      • 8.2.1.3. Product benchmarking
      • 8.2.1.4. Strategic initiatives
    • 8.2.2. Quidel Corporation
      • 8.2.2.1. Company overview
      • 8.2.2.2. Financial performance
      • 8.2.2.3. Product benchmarking
      • 8.2.2.4. Strategic initiatives
    • 8.2.3. Siemens Healthineers GmbH
      • 8.2.3.1. Company overview
      • 8.2.3.2. Financial performance
      • 8.2.3.3. Product benchmarking
      • 8.2.3.4. Strategic initiatives
    • 8.2.4. F. Hoffmann-La Roche Ltd.
      • 8.2.4.1. Company overview
      • 8.2.4.2. Financial performance
      • 8.2.4.3. Product benchmarking
      • 8.2.4.4. Strategic initiatives
    • 8.2.5. Danaher
      • 8.2.5.1. Company overview
      • 8.2.5.2. Financial performance
      • 8.2.5.3. Product benchmarking
      • 8.2.5.4. Strategic initiatives
    • 8.2.6. BIOMERIEUX
      • 8.2.6.1. Company overview
      • 8.2.6.2. Financial performance
      • 8.2.6.3. Product benchmarking
      • 8.2.6.4. Strategic initiatives
    • 8.2.7. Bio-Rad Laboratories, Inc.
      • 8.2.7.1. Company overview
      • 8.2.7.2. Financial performance
      • 8.2.7.3. Product benchmarking
      • 8.2.7.4. Strategic initiatives
    • 8.2.8. Randox Laboratories Ltd.
      • 8.2.8.1. Company overview
      • 8.2.8.2. Financial performance
      • 8.2.8.3. Product benchmarking
      • 8.2.8.4. Strategic initiatives
    • 8.2.9. Creative Diagnostics
      • 8.2.9.1. Company overview
      • 8.2.9.2. Financial performance
      • 8.2.9.3. Product benchmarking
      • 8.2.9.4. Strategic initiatives
    • 8.2.10. Life Diagnostics
      • 8.2.10.1. Company overview
      • 8.2.10.2. Financial performance
      • 8.2.10.3. Product benchmarking
      • 8.2.10.4. Strategic initiatives

List of Tables

  • Table 1 List of Abbreviation
  • Table 2 North America cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 3 North America cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 4 North America cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 5 North America cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 6 U.S. cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 7 U.S. cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 8 U.S. cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 9 Canada cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 10 Canada cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 11 Canada cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 12 Europe cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 13 Europe cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 14 Europe cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 15 Europe cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 16 Germany cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 17 Germany cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 18 Germany cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 19 UK cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 20 UK cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 21 UK cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 22 France cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 23 France cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 24 France cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 25 Italy cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 26 Italy cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 27 Italy cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 28 Spain cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 29 Spain cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 30 Spain cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 31 Denmark cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 32 Denmark cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 33 Denmark cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 34 Sweden cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 35 Sweden cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 36 Sweden cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 37 Norway cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 38 Norway cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 39 Norway cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 40 Asia Pacific cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 41 Asia Pacific cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 42 Asia Pacific cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 43 Asia Pacific cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 44 Japan cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 45 Japan cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 46 Japan cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 47 China cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 48 China cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 49 China cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 50 India cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 51 India cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 52 India cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 53 Australia cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 54 Australia cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 55 Australia cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 56 Thailand cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 57 Thailand cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 58 Thailand cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 59 South Korea cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 60 South Korea cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 61 South Korea cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 62 Latin America cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 63 Latin America cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 64 Latin America cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 65 Latin America cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 66 Brazil cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 67 Brazil cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 68 Brazil cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 69 Mexico cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 70 Mexico cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 71 Mexico cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 72 Argentina cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 73 Argentina cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 74 Argentina cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 75 Middle East and Africa cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 76 Middle East and Africa cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 77 Middle East and Africa cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 78 Middle East and Africa cardiac biomarkers market, by region, 2018 - 2030 (USD Million)
  • Table 79 South Africa cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 80 South Africa cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 81 South Africa cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 82 Saudi Arabia cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 83 Saudi Arabia cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 84 Saudi Arabia cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 85 UAE cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 86 UAE cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 87 UAE cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)
  • Table 88 Kuwait cardiac biomarkers market, by type, 2018 - 2030 (USD Million)
  • Table 89 Kuwait cardiac biomarkers market, by application, 2018 - 2030 (USD Million)
  • Table 90 Kuwait cardiac biomarkers market, by end use, 2018 - 2030 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Primary research pattern
  • Fig. 4 Market research approaches
  • Fig. 5 QFD modeling for market share assessment
  • Fig. 6 Market formulation & validation
  • Fig. 7 Cardiac biomarkers: Market outlook
  • Fig. 8 Cardiac biomarkers: Competitive insights
  • Fig. 9 Parent market outlook
  • Fig. 10 Related/ancillary market outlook
  • Fig. 11 Penetration and growth prospect mapping
  • Fig. 12 Cardiac biomarkers market driver impact
  • Fig. 13 Cardiac biomarkers market restraint impact
  • Fig. 14 Cardiac biomarkers market strategic initiatives analysis
  • Fig. 15 Cardiac biomarkers market: Type movement analysis
  • Fig. 16 Cardiac biomarkers market: Type outlook and key takeaways
  • Fig. 17 Troponin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 18 CK-MB market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 19 Myoglobin market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 20 BNP and NT-proBNP market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 21 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 22 Cardiac biomarkers market: Application movement analysis
  • Fig. 23 Cardiac biomarkers market: Application outlook and key takeaways
  • Fig. 24 Acute coronary syndrome market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 25 Myocardial infarction market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 26 Congestive heart failure market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 27 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 28 Cardiac biomarkers market: End use movement analysis
  • Fig. 29 Cardiac biomarkers market: End use outlook and key takeaways
  • Fig. 30 Laboratory testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 31 Point of care testing market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 32 Pain management market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 33 Cancer therapy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 34 Vaccine delivery market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 35 Others market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 36 Global cardiac biomarkers market: Regional movement analysis
  • Fig. 37 Global cardiac biomarkers market: Regional outlook and key takeaways
  • Fig. 38 North America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 39 U.S. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 40 Canada market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 41 Europe market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 42 UK market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 43 Germany market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 44 France market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 45 Italy market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 46 Spain market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 47 Denmark market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 48 Sweden market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 49 Norway market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 50 Asia Pacific market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 51 Japan market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 52 China market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 53 India market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 54 Australia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 55 Thailand market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 56 South Korea market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 57 Latin America market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 58 Brazil market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 59 Mexico market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 60 Argentina market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 61 Middle East and Africa. market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 62 South Africa market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 63 Saudi Arabia market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 64 UAE market estimates and forecasts, 2018 - 2030 (USD Million)
  • Fig. 65 Kuwait market estimates and forecasts, 2018 - 2030 (USD Million)